Butyrate-producing microbiota: what it can and cannot indicate

The mucin-nourishing microbiota and the butyrate-producing microbiota describe different functions, although they may be related within the gut ecosystem. Detecting microorganisms associated with these functions does not, by itself, confirm that those activities are taking place or establish a diagnosis.

In summary:

• Mucin-nourishing activity and butyrate production are distinct concepts; any possible relationship between them should be interpreted in light of the available evidence.
• Finding microorganisms linked to a function does not prove that the function is being carried out or allow a diagnosis to be made.
• Stool butyrate results should be assessed in light of the measurement method and the limitations of the sample.
• Metagenomics studies microorganisms, while metabolomics can provide information about metabolites; they answer different questions.

To study which metabolites, such as butyrate, are present, see the functional short-chain fatty acid metabolomics test. Results can inform interpretation, but should be assessed in the clinical context.

What does it mean for a microbiota to be muconutritive?

A muconutritive microbiota is a descriptive term for microorganisms and microbial activities associated with using components of the intestinal mucosa and maintaining it. It should not be interpreted as a diagnostic category in itself. Its precise meaning depends on how the term is defined in each context.

The mucosa includes a mucus layer containing mucins, molecules that can serve as substrates for some microorganisms. The term may therefore refer to interactions between the microbiota and this layer, rather than to a specific species or a uniform function shared by all bacteria. Its use should be clarified in the report or study that employs it.

If the aim is to characterise intestinal microorganisms, intestinal microbiota analysis examines their composition. Detecting microorganisms is not, on its own, enough to confirm what activity is taking place in the mucosa.

How do muconutritive function and butyrate production differ?

Muconutritive function describes microbial activities related to components of the intestinal mucosa, while butyrate production refers to the formation of this metabolite. They are distinct dimensions, and detecting evidence of one does not allow us to conclude that the other is present or active.

The practical difference lies in the question each concept addresses: one concerns the relationship between the microbiota and the mucosa; the other concerns the production of a specific molecule. They are therefore not interchangeable categories, and one does not necessarily imply the other.

Both functions may be related within the intestinal ecosystem, but this relationship should be interpreted with caution and in light of what each analysis measures. A microbial profile alone does not confirm that butyrate is being produced or allow muconutritive activity to be assessed.

When microbiome and functional data are assessed together, Xenogene’s integrated profiles bring together complementary information; interpretation should take into account the method used and the clinical context.

Which microorganisms are associated with butyrate production?

Some gut microorganisms are associated with metabolic pathways that can produce butyrate. However, this association does not establish that they are producing it in a specific sample: this capacity can vary between species and strains, and also depends on the conditions and substrates available in the gut ecosystem.

For this reason, butyrate production should not be attributed to the microbiota as a whole, nor should the detection of a microorganism be interpreted as proof of activity. To assess what a result indicates, it is important to distinguish between identifying microorganisms and detecting metabolic functions. These are related, but not equivalent, types of data.

An assessment of gut microorganisms, such as the Microbiota Esencial analysis, can provide information about which microorganisms are present. Attributing a specific function requires scientific evidence and should be interpreted alongside the method used and the clinical context.

What can faecal butyrate indicate, and what are its limitations?

Faecal butyrate indicates the amount of the metabolite detected in a stool sample, but it does not directly measure how much the microbiota produces or how much is used by the intestinal mucosa. Its meaning depends on the method, how the sample is collected and stored, and the clinical context.

Intestinal transit, stool composition and storage conditions can affect the result. For this reason, a single measurement cannot capture the full metabolic activity of the intestine or establish a disease or imbalance.

If inflammation is being investigated, faecal calprotectin addresses a different question and does not replace clinical interpretation of butyrate. A healthcare professional should assess the result alongside symptoms, medical history, the analytical method and the purpose of the test.

How can butyrate-related activity be studied?

To study butyrate-related activity, metagenomics analyses the genetic material of the microorganisms present, while metabolomics can measure metabolites such as butyrate in a sample. Metagenomics therefore provides insight into microbial potential, while metabolomics shows which compounds are detected; neither, on its own, establishes a diagnosis.

In practice, they answer different questions: detecting genes linked to a pathway does not confirm that the pathway is active. Measuring butyrate describes the metabolite detected in the sample, but does not identify which microorganisms produced it.

The choice depends on the question: microbial composition and genetic potential, or measured metabolites. Interpreting both results requires consideration of the clinical context and the method used. They can inform an assessment, but do not replace professional judgement. For more information, see the comparison of metagenomics and biochemistry.

Frequently asked questions

Does a low butyrate level mean I have a disease?

No. A low result on its own cannot establish that you have a disease or explain your symptoms. It should be interpreted in light of how it was measured, the information available about the sample and your clinical context. If you have a result that concerns you, discuss it with a healthcare professional, who can assess whether further tests are needed.

Can diet change butyrate production by the microbiota?

Diet can influence microbiota activity, but it is not possible to be certain that a particular change will increase butyrate in an individual. The response may depend on several factors, and a single result cannot show that a change was caused by a specific food or dietary approach. Speak to a healthcare professional before making changes for health reasons.

Does taking a probiotic necessarily increase intestinal butyrate?

Not necessarily. The effect cannot be assumed to apply to all probiotics or to everyone. Detecting or taking a microorganism does not, on its own, show that more butyrate is being produced. If you are considering a probiotic, speak to a healthcare professional and review the evidence supporting its use in your specific situation.

What should be reviewed before interpreting a butyrate result?

It is worth checking what the test analysed, how the result is presented and what limitations are described in the report. It is also important to give the healthcare professional the reason for the test and any relevant clinical information. This allows the result to be considered alongside other information, rather than interpreted as a diagnosis on its own.

View the short-chain fatty acid functional metabolomics test.